Back to results
US 5,565,352 AGranted
Deubiquitinating enzyme: compositions and methods
AssigneeArch Development Corporation
InventorsMark Hochstrasser, Feroz Papa
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeArch Development Corporation
InventorsMark Hochstrasser, Feroz Papa
Estimating the term…
The invention relates generally to compositions of and methods for obtaining deubiquitinating enzyme polypeptides. The invention relates as well to polynucleotides encoding deubiquitinating enzyme polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant deubiquitinating enzyme polypeptides. By way of example, the invention discloses the cloning and functional expression if at least three different deubiquitinating enzyme polypeptides. The invention includes as well, methods for using the isolated, recombinant enzyme polypeptides in assays designed to select and improve substances capable of interacting with deubiquitinating enzyme polypeptides for use in diagnostic, drug design and therapeutic applications.
An isolated and purified polynucleotide that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:
An expression vector comprising a polynucleotide that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:
A recombinant host cell transfected with a polynucleotide that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:
An isolated yeast cell containing a mutated DOA4 gene, which mutated gene encodes a DOA4 enzyme that does not catalyze the deubiquitination of proteins.
Dependencies are inferred from the claim text.